Home / Leaderboard / Exor N.V.
Exor N.V.
John Elkann · Family Office · Value
Exor N.V. is a prominent European diversified holding company controlled by the Agnelli family, with roots tracing back to the founding of FIAT in 1899 by Giovanni Agnelli. Headquartered in Amsterdam, the firm operates as a long-term value investor, focusing on building and nurturing a portfolio of market-leading companies across diverse sectors, including automotive, healthcare, technology, and media. Key holdings include significant stakes in Ferrari, Stellantis, CNH Industrial, and Philips. Exor combines an entrepreneurial spirit with rigorous financial discipline, aiming to achieve capital appreciation and deliver superior returns through active ownership and strategic support of its portfolio companies. The institution is known for its multi-generational investment horizon, often holding assets for decades while maintaining a commitment to corporate social responsibility and sustainable growth.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | -4.8% |
| YTD return | -2.4% |
| Sharpe ratio | -0.80 |
| Win rate | 25% |
| AUM | $6.4B |
| Inception | Oct 1, 2025 |
| Updated | Sep 4, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $6.4B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | https://www.exor.com |
Current Holdings
Updated on Sep 4, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| PHG | Koninklijke Philips NV ADR | 82.9% | -6.3% |
| RYCEY | Rolls Royce Holdings plc | 10.4% | 0.0% |
| VIA | Via Transportation, Inc. | 4.6% | +36.8% |
| CLVT | CLARIVATE PLC | 2.1% | -45.2% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Feb 9, 2026 | BUY | VIA | 0.0% → 4.6% |
| Feb 9, 2026 | SELL | CLVT | 2.8% → 2.1% |
| Feb 9, 2026 | SELL | PHG | 86.8% → 82.9% |
| Feb 9, 2026 | SELL | RYCEY | 10.4% → 10.4% |
| Oct 1, 2025 | BUY | PHG | 0.0% → 85.2% |
Investment Style Analysis
Exor N.V. is widely recognized for employing a Value strategy. As of Sep 4, 2026, the firm oversees approximately $6.4B in assets under management (AUM). The portfolio demonstrates a clear preference for the Medical Devices and Aerospace & Defense sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Feb 9, Exor N.V. made a significant move by increasing exposure to VIA. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
Exor’s investment philosophy is centered on the principle of building great companies through a combination of entrepreneurial spirit and financial discipline. The firm adopts a permanent capital approach, prioritizing long-term value creation over short-term market fluctuations rather than following standard exit cycles. It seeks to invest in businesses with clear competitive advantages, outstanding management, and significant growth potential, often taking large stakes to exercise active governance. Exor acts as a partner to its portfolio companies, providing strategic support and fostering a culture of innovation and responsibility while respecting operational autonomy. Its strategy is guided by core values of ambition, humility, curiosity, and patience.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Exor N.V..
Similar Investment Style
Based on Value.
- Corstar Holdings, Inc. — Jeffrey J. Michael · 3M +14.0%
- Systematic Financial Management LP — Kenneth Burgess · 3M -7.0%
- Penn Capital Management Company, LLC — Richard A. Hocker · 3M -3.9%
- Reinhart Partners, LLC — James Reinhart · 3M +5.5%
Frequently asked questions
How is the simulated portfolio for Exor N.V. constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Exor N.V.'s largest holding?
As of the latest filing, Exor N.V.'s top position is Koninklijke Philips NV ADR (PHG), representing 82.9% of the portfolio. This reflects a high-conviction bet by the institution.
What is Exor N.V.'s historical performance and risk profile?
Our simulation indicates a total return of -4.8% with a win rate of 25%. Notably, the portfolio maintains a Sharpe Ratio of -0.80, suggesting an standard level of risk-adjusted returns compared to the broader market.
What sectors does Exor N.V. primarily invest in?
Exor N.V. has a strong preference for the Medical Devices sector, which makes up 82.9% of their disclosed assets. The portfolio also has exposure to Aerospace & Defense, indicating a specific thematic focus.
Is Exor N.V.'s portfolio concentrated or diversified?
Exor N.V. runs a highly concentrated portfolio with 4 disclosed positions. The top 3 holdings alone account for 97.9% of the total portfolio weight, suggesting a strategy that favors deep research into a few key names.
How has Exor N.V. performed in 2026?
Our AI-simulated model portfolio for Exor N.V. tracks a Year-to-Date (YTD) return of -2.4%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does John Elkann manage Exor N.V. directly?
Yes, John Elkann serves as the key portfolio manager for Exor N.V., overseeing the investment strategy and final capital allocation decisions.